PT Kalbe Farma Tbk. (IDX:KLBF)

Market Cap	34.84T -38.1%
Revenue (ttm)	36.21T +9.6%
Net Income	3.62T +7.7%
EPS	79.64 +9.1%
Shares Out	45.25B
PE Ratio	9.67
Forward PE	9.38
Dividend	36.00 (4.68%)
Ex-Dividend Date	Jun 4, 2026

Volume	152,486,900
Open	795.00
Previous Close	795.00
Day's Range	765.00 - 795.00
52-Week Range	765.00 - 1,600.00
Beta	0.01
Analysts	Strong Buy
Price Target	1,438.75 (+86.85%)
Earnings Date	Jul 30, 2026

About PT Kalbe Farma Tbk.

PT Kalbe Farma Tbk., together with its subsidiaries, engages in the development, manufacture, and trading of pharmaceutical products in Indonesia. It operates through Prescription Pharmaceuticals; Consumer Health; Nutritionals; and Distribution and Logistic segments. The company provides prescription/ethical; consumer health; nutritionals; distribution and logistics; health services; medical devices; biopharma; animal health; international business, and E-health products. In addition, the company provides health screening services; operates as ...

• Industry: Drug Manufacturers - General
• Sector: Healthcare
• Founded: 1966
• Employees: 12,895
• Stock Exchange: Indonesia Stock Exchange
• Ticker Symbol: KLBF

Financial Performance

In 2025, PT Kalbe Farma Tbk.'s revenue was 35.32 trillion, an increase of 8.27% compared to the previous year's 32.63 trillion. Earnings were 3.66 trillion, an increase of 13.09%.